Priority to Cryopreservation Strategy (PCS) in IVF-ICSI Cycles
PCS
1 other identifier
interventional
1,000
1 country
1
Brief Summary
This multicentre randomized controlled trial will be done to evaluate a new strategy in IVF-ICSI practice that gives that priority to freeze for the embryos and goes to fresh embryo transfer only if at least one set of same quality embryos is available for cryopreservation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2019
CompletedFirst Posted
Study publicly available on registry
April 12, 2019
CompletedStudy Start
First participant enrolled
May 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJuly 18, 2023
July 1, 2023
5.7 years
April 10, 2019
July 15, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Cumulative pregnancy rates
The number of pregnant women in both groups after 3 cycles
3 months
Secondary Outcomes (1)
Failure of pregnancy
3 months
Study Arms (2)
Study group
EXPERIMENTALWill be subjected to priority to freeze
Control group
ACTIVE COMPARATORWill receive fresh embryo transfere
Interventions
Priority for cryopreservation and later on embryo transfer in artificial cycle with endometrium preparation by the exogenous administration of estrogen-progesterone.
usual strategy of giving the priority for fresh embryo transfer
Eligibility Criteria
You may qualify if:
- Candidates for IVF/ICSI
- Presence of good number of embryos \> 5
You may not qualify if:
- Low quality embryos
- Low ovarian reserve
- Low number of embryos
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Ayman Shehata Dawood
Tanta, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ahmed Elhalwagy, MD
Tanta Universit
- STUDY CHAIR
Yaser Mesbah, MD
Mansiura University
- STUDY CHAIR
Ahmed Abbas, MD
Assiut University
- STUDY CHAIR
Ahmed Elsawaf, MD
Cairo University
- STUDY CHAIR
Shereef Elshowaikh, MD
Tanta University
- STUDY CHAIR
Abdelghaffar Dawood, MD
Tanta University
- STUDY CHAIR
Ahmed Elkhyat, MD
Tanta University
- STUDY CHAIR
Shereen Elbohoty, MD
Tanta University
- STUDY CHAIR
Waleed Mamdouh, MD
Tanta University
- STUDY CHAIR
Mahmoud Soliman, MD
Cairo University
- STUDY CHAIR
Waleed Tawfeek, MD
Benha University
- STUDY CHAIR
Ahmed Saber, MD
Benha University
- STUDY CHAIR
Amr Abdelrahman
Zagazig University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
April 10, 2019
First Posted
April 12, 2019
Study Start
May 1, 2019
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
July 18, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- 3 months
We will decide the type of data to share